Sodium Diatrizoate (Sodium Diatrizoate)
Overview of Sodium Diatrizoate
Sodium Diatrizoate used in diagnostic radiography.
Indication of Sodium Diatrizoate
Indications
Contraindication of Sodium Diatrizoate
Sodium Diatrizoate is contraindicated in conditions like Asthma,Phaeochromocytoma,Myeloma,Renal impairment,Sickle cell disease.
Side Effects of Sodium Diatrizoate
The severe or irreversible adverse effects of Sodium Diatrizoate, which give rise to further complications include Tachycardia, Pancreatitis, Bradycardia, Renal impairment.,Sodium Diatrizoate produces potentially life-threatening effects which include Pulmonary edema, Cardiac arrhythmia, Bronchospasm, Angioneurotic edema, Anaphylactic reactions, Hypertensive crises. which are responsible for the discontinuation of Sodium Diatrizoate therapy.,The symptomatic adverse reactions produced by Sodium Diatrizoate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Weakness, Dizziness, Headache, Nausea, Vomiting, Sweating, Flushing, Faintness, Taste disturbances, Metallic taste, Sensation of warmth.
Precautions of Sodium Diatrizoate
It should be used with caution in patients with previous reaction to diatrizoates or any other iodinated contrast agent and patient with allergies to other drugs. Diatrizoate should be administered with great caution in patients with asthma and history of allergy, and should be avoided to patients with known hypersensitivity to iodine or contrast media. An IV injection of 0.5 to 1 ml of contrast media has been given as a test for sensitivity before administration of main dose. Caution is needed in patients with severe hepatic (liver) or renal impairment or who may be at a risk of renal failure. Dehydration patients should have their fluid and electrolyte balance corrected before administration of contrast medium. It should be used with extreme caution in patients with hypertension, cardiac disease, phaeochromocytoma, sickle-cell anemia or hypothyroidism. Avoid use during pregnancy.